FBInvestor
Stocks / Igc Pharma Inc
Institutional Ownership

Igc Pharma Inc

CUSIP 45408X308COM NEWIGCQ1 2026

13D / 13G Filings
2
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
18.3%
Max % of class reported
Institutional Holders
32
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

2 filings · latest Aug 14, 2024

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Aug 14, 2024Bradbury Strategic Investment Fund A (Cayman Islands Registration No. Cr-359857)13D/A18.3%13.82MSEC
2May 21, 2024Bradbury Strategic Investment Fund A (Cayman Islands Registration No. Cr-359857)13D18.3%13.82MSEC

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →
#FundSharesValue
1Geode Capital Management, LLC1.04M$274.4K
2Blackrock, Inc.703.8K$185.1K
3Renaissance Technologies LLC484.0K$127.3K
4State Street Corp200.8K$52.8K
5Susquehanna International Group, LLP122.6K$32.2K
6Northern Trust Corp113.4K$29.8K
7Lawood & Co75.0K$19.7K
8Goldman Sachs Group Inc65.5K$17.2K
9Dearborn Partners LLC59.4K$15.6K
10Xtx Topco Ltd50.6K$13.3K